A Clinical Trial to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001